Agilent Technologies (A) Peer Comparison
$164.03
As on 23-Sep-2026 15:41EDT
Market cap
$44,113 Mln
Revenue (TTM)
$7,372 Mln
P/E Ratio
30.9
P/B Ratio
6
Div. Yield
0.7 %
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
44,113 | 118,666 | 42,703 | 10,514 | 99 |
Revenue ($ Mln) |
7,372 | 37,542 | 3,458 | 4,237 | 2 |
Net Profit ($ Mln) |
1,440.00 | 5,230.00 | 1,014.77 | 570.30 | -6.96 |
Net Margin (%) |
19.53 | 13.93 | 29.34 | 13.46 | -430.43 |
RoE (%) |
20.18 | 10.47 | 13.86 | 6.83 | -115.97 |
Price to Earnings |
30.86 | 22.85 | 43.45 | 18.49 | -- |
Price-To-Book |
5.99 | 2.36 | 5.77 | 1.23 | 18.49 |
Income Statement ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,948.00 | 33,537.00 | 2,746.62 | 4,092.40 | 2.14 |
|
Cost of Revenue
|
3,305.00 | 11,632.00 | 699.64 | 1,609.50 | 1.44 |
|
Gross Profit
|
3,643.00 | 21,905.00 | 2,046.98 | 2,482.90 | 0.70 |
|
Operating Expenses
|
2,164.00 | 15,950.00 | 1,355.55 | 1,800.00 | 7.39 |
|
Operating Profit (EBIT)
|
1,479.00 | 5,955.00 | 691.44 | 682.90 | -6.69 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
1,435.00 | 5,628.00 | 919.38 | 566.50 | -10.48 |
|
Provision for Tax
|
132.00 | 936.00 | 205.24 | 191.60 | 0.00 |
|
Profit after Tax (Net Income)
|
1,303.00 | 4,662.00 | 714.14 | 374.90 | -10.48 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
1,303.00 | 4,662.00 | -- | -- | -- |
Liabilities ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,741.00 | 48,024.00 | 5,832.37 | 8,238.90 | 6.43 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
3,639.00 | 30,545.00 | 108.98 | 3,042.90 | 0.06 |
|
Current Liabilities
|
2,347.00 | 12,879.00 | 1,398.40 | 1,112.80 | 0.98 |
|
Total Liabilities
|
12,727.00 | 91,680.00 | 7,339.76 | 12,394.80 | 7.47 |
Assets ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
8,133.00 | 67,865.00 | 1,030.95 | 10,288.40 | 2.68 |
|
Current Assets
|
4,594.00 | 23,814.00 | 6,308.80 | 2,106.40 | 4.79 |
|
Total Assets
|
12,727.00 | 91,680.00 | 7,339.76 | 12,394.80 | 7.47 |
|
Total Debt*
|
3,354.00 | 28,516.00 | 75.78 | 2,783.60 | 0.19 |
|
Net Current Assets
|
2,247.00 | 10,935.00 | 4,910.40 | 993.60 | 3.81 |
Cashflow ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,559.00 | 7,044.00 | 1,090.05 | 796.10 | -4.63 |
|
Cash Flow from Investing Activities
|
-394.00 | -1,937.00 | -700.14 | -372.90 | -0.09 |
|
Cash from Financing Activities
|
-715.00 | -4,361.00 | 26.12 | -425.90 | 8.54 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.32 | 6.14 | 13.46 | 3.46 | -157.70 |
|
ROE (%)
|
20.62 | 9.49 | 13.63 | 4.59 | -162.94 |
|
ROA (%)
|
10.61 | 5.13 | 10.78 | 3.03 | -139.89 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
18.75 | 13.90 | 26.00 | 9.16 | -489.86 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.07 | 0.04 | 0.16 | 0.05 | 0.03 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
1.09 | 26.82 | 35.84 | -4.44 | -91.11 |
|
EPS Growth (%)
|
-- | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -- | -- |
|
Price / Book Value
|
-- | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.85 | 2.12 | -5.29 | 2.54 | 0.41 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.50 | 0.59 | 0.01 | 0.34 | 0.03 |
|
Short term debt to equity ratio
|
0.05 | 0.06 | 0.00 | 0.01 | 0.02 |
|
Current Ratio
|
1.96 | 1.85 | 4.51 | 1.89 | 4.88 |
|
Quick Ratio
|
1.52 | 1.42 | -- | 1.13 | 4.66 |
|
Interest Coverage
|
13.81 | 8.72 | -- | 6.30 | -488.67 |
Operating Efficiency Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
21.40 | 19.43 | 38.49 | 20.26 | 3.45 |
|
Asset Turnover
|
0.57 | 0.37 | 0.41 | 0.33 | 0.29 |
|
Receivable days
|
73.89 | 68.85 | 129.37 | 68.99 | 18.99 |
|
Inventory Days
|
111.40 | 167.88 | 0.00 | 187.07 | 48.27 |
|
Payable days
|
61.34 | 76.29 | 16.17 | 63.64 | 174.88 |
|
Cash Conversion Cycle
|
123.95 | 160.44 | 109.59 | 192.42 | -107.62 |